These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1158 related items for PubMed ID: 17826485

  • 1. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML, Stein JP, Nichols PW, Cai J, Miranda G, Groshen S, Daneshmand S, Skinner EC, Skinner DG.
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 20; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 5. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B.
    BJU Int; 2008 Sep 20; 102(8):952-7. PubMed ID: 18485042
    [Abstract] [Full Text] [Related]

  • 6. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Sep 20; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 7. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 20; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jul 20; 30(7):2973-6. PubMed ID: 20683041
    [Abstract] [Full Text] [Related]

  • 9. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec 20; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B, Park S, Hong JH, Kim CS, Ro JY, Ahn H.
    Urology; 2005 Apr 20; 65(4):692-6. PubMed ID: 15833510
    [Abstract] [Full Text] [Related]

  • 11. Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma.
    Kim DS, Lee YH, Cho KS, Cho NH, Chung BH, Hong SJ.
    Urology; 2010 Feb 20; 75(2):328-32. PubMed ID: 20018349
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 20; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 13. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct 20; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan 20; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M, Tao R, Zhang C, Shen Z.
    Urology; 2010 Oct 20; 76(4):902-7. PubMed ID: 20709377
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 20; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM, Simons CM, Konety BR, Muirhead DM, Williams RD, O'Donnell MA, Joudi FN.
    BJU Int; 2009 Feb 20; 103(4):475-9. PubMed ID: 18990174
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG, Palapattu GS, Shariat SF, Karakiewicz PI, Bastian PJ, Lotan Y, Gupta A, Vazina A, Gilad A, Sagalowsky AI, Lerner SP, Schoenberg MP.
    J Urol; 2006 Jun 20; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [Abstract] [Full Text] [Related]

  • 19. Radical cystectomy in the elderly: Comparison of survival between younger and older patients.
    Clark PE, Stein JP, Groshen SG, Cai J, Miranda G, Lieskovsky G, Skinner DG.
    Cancer; 2005 Feb 01; 103(3):546-52. PubMed ID: 15630702
    [Abstract] [Full Text] [Related]

  • 20. [Clinical analysis of bladder cancer patients treated by radical cystectomy].
    Kageyama S, Yoshiki T, Hamaguchi A, Konishi T, Okada Y, Park KI, Tomoyoshi T.
    Hinyokika Kiyo; 1997 Jan 01; 43(1):1-6. PubMed ID: 9046413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.